Health Medicine Network
Two tablets a day could soon save some blood cancer patients from grueling periods of chemotherapy. The drug, called ruxolitinib, can keep a type of blood cancer called polycythemia vera in remission for up to three years longer than traditional methods, according to British research. About one-third of patients with […] https://healthmedicinet.com/i/patients-with-blood-cancer-can-be-spared-chemotherapy-with-two-daily-tablets/
Breaking News
- How more VEG eaten may make you fat in middle-age
- How peptic ulcer disease can lead to life-threatening complications
- How higher exposure of oestrogen may lead to a lower risk of dementia
- Comment les Keto XP Gummies sont utiles?
- How biological different patients may have long-term Covid conditions
- How PANGOLINS strain of Covid virus is nearly identical to the strain in humans
- How drug overdose statistics show no impact from Decriminalizing DRUGS
- How to detect prostate cancer with 94% accuracy
- How society negatively impact the way women approach cancer prevention
- What are the three activities that don’t bring enough benefit to life and carry too much risk
- How a parasitic worm may cause a potentially fatal brain infection
- What are the Aloe Vera benefits
- How to trick muscles into thinking they’re working hard
- How eating pesto contaminated with deadly bacteria may lead to coma
- How obsessive-compulsive disorder made him scared of touching food with his hands